Skip to main content
. 2009 Jan 6;100(2):412–420. doi: 10.1038/sj.bjc.6604820

Table 2. Summary odds ratio (per allele) and 95% confidence interval for risk of invasive epithelial ovarian cancer among the indicated OCAC studies for SNPs that showed no association with ovarian cancer.

Gene SNP Controls (N) Cases (N) ORheta (95% CI) P-value ORhoma (95% CI) P-value Studies
COMT rs4680 874 381 1.01 (0.75–1.36) 0.96 1.00 (071–1.42) 0.98 HAWAII, MAYO OVCARE
CYP1A1 rs4646903 1182 490 1.15 (0.89–1.50) 0.29 0.77 (0.28–2.13) 0.61 HAWAII, NECC, OVCARE
CYP1A1 rs1048943 1308 611 1.13 (0.79–1.63) 0.50 0.97 HAWAII, MAYO, NECC, OVCARE
CYP1B1 rs1056836 875 384 0.91 (0.69–1.21) 0.52 0.83 (0.58–1.19) 0.31 HAWAII, MAYO OVCARE
CYP17 rs743572 1594 1078 1.09 (0.91–1.30) 0.36 1.19 (0.93–1.52) 0.17 HAWAII, NCOCS, NECC, SWH, USC
ESR2 rs3020450 2198 1523 0.95 (0.83–1.10) 0.52 1.09 (0.87–1.36) 0.44 HAWAII, NCOCS, NECC, USC
XRCC3 rs861539 5186 2352 0.92 (0.82–1.04) 0.17 1.01 (0.85–1.19) 0.95 AOCS, MALOVA, NCOCS, SEARCH, GEOCS, SWH
a

CI=confidence interval; het=heterozygous carriers; hom=homozygous carriers; OR=odds ratio. All ORs stratified on study site, race/ethnicity and age.